The effect of high-dose angiotensin II receptor blockade beyond maximal recommended doses in reducing urinary protein excretion
The optimal doses of angiotensin-converting enzyme inhibitors (ACE-I) and/or angiotensin II receptor blockers (ARBs) for maximal reduction in urinary protein excretion are not known. Moreover, beneficial effects from ARBs, such as tissue protection owing to a more complete blockade of the renin-angi...
Main Authors: | Marc S Weinberg, Adam J Weinberg, Raymond Cord, Dion H Zappe |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2001-03-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/14703203010020013401 |
Similar Items
-
Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors
by: Marc S Weinberg, et al.
Published: (2000-09-01) -
Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure
by: Sam Hanon, et al.
Published: (2000-06-01) -
Efficacy of low-dose spironolactone on top of angiotensin receptor blockade in patients with glomerulonephritis
by: Byung Chul Yu, et al.
Published: (2018-09-01) -
Influence of riboflavin doses on the urinary excretion of riboflavin and 4-pyridoxic acid in young men
by: Ottinger, Joan Marie
Published: (2012) -
Urinary riboflavin excretions and test dose return of healthy women as affected by dietary nitrogen
by: Nakka, Gail Sandra.
Published: (2013)